Our results indicate that increasing concentrations of anti-desmoglein-2 antibodies correlate with the degree of left ventricular dilatation in dogs with structural cardiac disease, regardless of whether that disease is ARVC, DCM, or MMVD. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.